Garrett R. Rettig

2.5k total citations · 1 hit paper
19 papers, 1.2k citations indexed

About

Garrett R. Rettig is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Garrett R. Rettig has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Genetics and 4 papers in Oncology. Recurrent topics in Garrett R. Rettig's work include CRISPR and Genetic Engineering (10 papers), Virus-based gene therapy research (8 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Garrett R. Rettig is often cited by papers focused on CRISPR and Genetic Engineering (10 papers), Virus-based gene therapy research (8 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Garrett R. Rettig collaborates with scholars based in United States, Israel and Japan. Garrett R. Rettig's co-authors include Mark A. Behlke, Kevin G. Rice, Rolf Turk, Matthew McNeill, Ashley M. Jacobi, Michael A. Collingwood, Shuqi Yan, Matthew H. Porteus, Christopher A. Vakulskas and Nicole M. Bode and has published in prestigious journals such as Nature Medicine, Nature Communications and Blood.

In The Last Decade

Garrett R. Rettig

19 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells

2018 541 citations Christopher A. Vakulskas, Daniel P. Dever et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Garrett R. Rettig United States	14	1.1k	331	137	90	84	19	1.2k
Shantanu Kumar United States	9	1.1k 1.0×	381 1.2×	137 1.0×	55 0.6×	70 0.8×	14	1.3k
Emma Haapaniemi Finland	4	829 0.7×	260 0.8×	146 1.1×	87 1.0×	79 0.9×	6	934
Michael A. Collingwood United States	10	1.5k 1.3×	444 1.3×	184 1.3×	75 0.8×	143 1.7×	11	1.6k
David A. Shivak United States	9	856 0.8×	508 1.5×	192 1.4×	57 0.6×	57 0.7×	10	1.0k
Rhiannon K. Macrae United States	18	1.3k 1.2×	299 0.9×	85 0.6×	113 1.3×	90 1.1×	33	1.6k
Daniel J. Wiegand United States	6	1.3k 1.2×	204 0.6×	74 0.5×	47 0.5×	74 0.9×	6	1.4k
Josephine M. Janssen Netherlands	20	1.2k 1.1×	466 1.4×	91 0.7×	42 0.5×	134 1.6×	27	1.3k
Luis Barrera United States	16	1.3k 1.2×	355 1.1×	129 0.9×	108 1.2×	69 0.8×	22	1.5k
Daniel E. Ryan United States	9	1.4k 1.3×	281 0.8×	151 1.1×	51 0.6×	113 1.3×	11	1.5k
Richard Gabriel Germany	16	1.0k 0.9×	531 1.6×	205 1.5×	102 1.1×	97 1.2×	28	1.3k

Countries citing papers authored by Garrett R. Rettig

Since Specialization

Citations

This map shows the geographic impact of Garrett R. Rettig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garrett R. Rettig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garrett R. Rettig more than expected).

Fields of papers citing papers by Garrett R. Rettig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garrett R. Rettig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garrett R. Rettig. The network helps show where Garrett R. Rettig may publish in the future.

Co-authorship network of co-authors of Garrett R. Rettig

This figure shows the co-authorship network connecting the top 25 collaborators of Garrett R. Rettig. A scholar is included among the top collaborators of Garrett R. Rettig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garrett R. Rettig. Garrett R. Rettig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Xiang, Jingyu, Jessica M. Devenport, Karl Staser, et al.. (2023). An “Off-the-Shelf” CD2 Universal CAR-T Therapy Combined with a Long-Acting IL-7 for T-Cell Malignancies. Blood. 142(Supplement 1). 764–764. 3 indexed citations

Cromer, M. Kyle, Garrett R. Rettig, Karthik Murugan, et al.. (2023). Comparative analysis of CRISPR off-target discovery tools following ex vivo editing of CD34+ hematopoietic stem and progenitor cells. Molecular Therapy. 31(4). 1074–1087. 19 indexed citations

Xiang, Jingyu, Jessica M. Devenport, Karl Staser, et al.. (2023). An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies. Leukemia. 37(12). 2448–2456. 24 indexed citations

Thommandru, Bernice, M. S. Swaminathan, Aruna D. Balgi, et al.. (2023). Lipid Nanoparticle-Mediated Gene Editing of Human Primary T Cells and Off-Target Analysis of the CRISPR-Cas9 Indels. Blood. 142(Supplement 1). 6833–6833. 6 indexed citations

Magis, Wendy, Mark A. DeWitt, Stacia K. Wyman, et al.. (2022). High-level correction of the sickle mutation is amplified in vivo during erythroid differentiation. iScience. 25(6). 104374–104374. 29 indexed citations

Kurgan, Gavin, Rolf Turk, Heng Li, et al.. (2021). CRISPAltRations: A validated cloud-based approach for interrogation of double-strand break repair mediated by CRISPR genome editing. Molecular Therapy — Methods & Clinical Development. 21. 478–491. 13 indexed citations

Magis, Wendy, Mark A. DeWitt, Stacia K. Wyman, et al.. (2021). High-Level Correction of the Sickle Mutation is Amplified in Vivo During Erythroid Differentiation. SSRN Electronic Journal. 1 indexed citations

Schubert, Mollie S., Bernice Thommandru, Jessica Woodley, et al.. (2021). Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair. Scientific Reports. 11(1). 19482–19482. 64 indexed citations

Kurgan, Gavin, Matthew McNeill, Garrett R. Rettig, et al.. (2021). CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS data. Nature Communications. 12(1). 3042–3042. 26 indexed citations

10.

Jacobi, Ashley M., Matthew McNeill, Rolf Turk, et al.. (2020). Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System. Molecular Therapy — Methods & Clinical Development. 17. 1097–1107. 42 indexed citations

11.

Vakulskas, Christopher A., Daniel P. Dever, Garrett R. Rettig, et al.. (2018). A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells. Nature Medicine. 24(8). 1216–1224. 541 indexed citations breakdown →

12.

Jacobi, Ashley M., Garrett R. Rettig, Rolf Turk, et al.. (2017). Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes. Methods. 121-122. 16–28. 102 indexed citations

13.

Rettig, Garrett R. & Mark A. Behlke. (2011). Progress Toward In Vivo Use of siRNAs-II. Molecular Therapy. 20(3). 483–512. 175 indexed citations

14.

Rettig, Garrett R. & Kevin G. Rice. (2009). Quantitative In Vivo Imaging of Non-viral-Mediated Gene Expression and RNAi-Mediated Knockdown. Methods in molecular biology. 574. 155–171. 7 indexed citations

15.

Rettig, Garrett R., et al.. (2007). Potency of siRNA versus shRNA mediated knockdown in vivo. Journal of Pharmaceutical Sciences. 96(11). 2922–2930. 67 indexed citations

16.

Rettig, Garrett R. & Kevin G. Rice. (2007). Non-viral gene delivery: from the needle to the nucleus. Expert Opinion on Biological Therapy. 7(6). 799–808. 32 indexed citations

17.

Chen, Changpo, Ji‐Seon Kim, Dijie Liu, et al.. (2007). Synthetic PEGylated Glycoproteins and Their Utility in Gene Delivery. Bioconjugate Chemistry. 18(2). 371–378. 28 indexed citations

18.

Rettig, Garrett R., et al.. (2006). Quantitative bioluminescence imaging of transgene expression in vivo. Analytical Biochemistry. 355(1). 90–94. 48 indexed citations

19.

Rettig, Garrett R., et al.. (2006). 401. Quantitative Bioluminescence Imaging of Transgene Expression In Vivo. Molecular Therapy. 13. S154–S154. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact